Steven Boyd
CIK 1706140 · last filed 2022-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.93B
Companies
15
Total Filings
62
Lifetime Open-Market Net
$30.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TENX | Director | 3,727,990 | $11.48 | $42.80M | $1.54M | 4 | 2022-05-19 |
| AVTX | Director | 47,302,442 | $14.76 | $698.18M | $39.40M | 3 | 2022-03-07 |
| Vyome Holdings, Inc (RSLS) Delisted | 10%+ Owner | 2,053,579 | $15.68 | $32.20M | -$28.46M | 1 | 2021-06-22 |
| Vaxart, Inc. (VXRT) Delisted | Director | 15,600,000 | $0.32 | $4.99M | -$53.29M | 7 | 2020-06-03 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 52,418,772 | $2.93 | $153.59M | $28.90M | 7 | 2020-03-16 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 8,138,000 | — | — | $20.47M | 3 | 2020-01-13 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 0 | — | — | -$1.73M | 4 | 2019-12-23 |
| AYTU | Director | 15,848,000 | $2.15 | $34.07M | $203.2K | 1 | 2019-12-23 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | Director | 6,260,000 | — | — | $13.27M | 6 | 2019-05-09 |
| BPTH | 10%+ Owner | 258,596 | $0.04 | $9.1K | -$514.9K | 1 | 2019-01-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 4,340,000 | — | — | -$5.64M | 2 | 2019-01-14 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 4,336,000 | — | — | -$3.83M | 1 | 2018-08-20 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | Director | 34,960,000 | — | — | $16.58M | 7 | 2018-08-20 |
| EYEG | 10%+ Owner | 32,745,000 | $35.27 | $1.15B | $3.96M | 2 | 2018-04-27 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 13,864,000 | $5.54 | $76.81M | $68.4K | 1 | 2018-02-09 |
Recent Filings · Page 6 of 7
62 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-20 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −3,768,000 | -$3.83M | EDGAR |
| 2018-08-20 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +3,000,000 | $11.73M | EDGAR |
| 2018-08-01 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +8,565 | $36.4K | EDGAR |
| 2018-07-18 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +90,057 | $385.2K | EDGAR |
| 2018-07-02 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +54,600 | $224.3K | EDGAR |
| 2018-06-18 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Buy (P) | +128,535 | $150.2K | EDGAR |
| 2018-05-17 | Avalo Therapeutics, Inc. (CERCW) Delisted | Buy (P) | +390,000 | $1.40M | EDGAR |
| 2018-04-27 | EYEG | Buy (P) | +496,566 | $267.8K | EDGAR |
| 2018-04-20 | EYEG | Buy (P) | +7,603,434 | $3.69M | EDGAR |
| 2018-02-09 | ALIMERA SCIENCES INC (ALIM) Delisted | Buy (P) | +60,000 | $68.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.